Abstract
Biopolymers made up of silk proteins have been used in numerous drug delivery applications and represent an excellent source of natural biomaterials. In particular silk fibroin has proved valuable as a building block for nanomedicines and drug delivery implants, owing to its favorable biocompatibility, degradation, stabilization and controllability. In this chapter we will discuss the various sources of silk biomaterial and how this naturally occurring biopolymer has been utilized in the development of nanomedicines and implantable drug delivery systems, demonstrating how silk is a unique biological template which has opened up many possibilities for the generation of functional biomaterials and drug delivery systems in a green and cost-effective manner.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cao Y, Wang B (2009) Biodegradation of silk biomaterials. Int J Mol Sci 10:1514–1524. doi:10.3390/ijms10041514
Acharya C, Ghosh S, Kundu S (2008) Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion. J Mater Sci Mater Med 19:2827–2836. doi:10.1007/s10856-008-3408-3
Panilaitis B et al (2003) Macrophage responses to silk. Biomaterials 24:3079–3085. doi:10.1016/S0142-9612(03)00158-3
Meinel L et al (2005) The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26:147–155. doi:10.1016/j.biomaterials.2004.02.047
Kuhbier J et al (2010) Interactions between spider silk and cells—NIH/3T3 fibroblasts seeded on miniature weaving frames. PLoS One 5:e12032. doi:10.1371/journal.pone.0012032
Allmeling C, Jokuszies A, Reimers K, Kall S, Vogt P (2006) Use of spider silk fibres as an innovative material in a biocompatible artificial nerve conduit. J Cell Mol Med 10:770–777. doi:10.1111/j.1582-4934.2006.tb00436.x
Hakimi O et al (2010) Modulation of cell growth on exposure to silkworm and spider silk fibers. J Biomed Mater Res A 92:1366–1372. doi:10.1002/jbm.a.32462
Vollrath F, Barth P, Basedow A, Engstrom W, List H (2002) Local tolerance to spider silks and protein polymers in vivo. In Vivo 16:229–234
Gellynck K et al (2008) Biocompatibility and biodegradability of spider egg sac silk. J Mater Sci Mater Med 19:2963–2970. doi:10.1007/s10856-007-3330-0
Numata K, Kaplan D (2010) Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev 62:1497–1508. doi:10.1016/j.addr.2010.03.009
Vepari C, Kaplan D (2007) Silk as a biomaterial. Prog Polym Sci 32:991–1007. doi:10.1016/j.progpolymsci.2007.05.013
Omenetto FG, Kaplan DL (2010) New opportunities for an ancient material. Science 329:528–531. doi:10.1126/science.1188936
Peakall DB (1969) Synthesis of silk, mechanism and location. Integr Comp Biol 9:71. doi:10.1093/icb/9.1.71
Andersson M, Holm L, Ridderstråle Y, Johansson J, Rising A (2013) Morphology and composition of the spider major ampullate gland and dragline silk. Biomacromolecules 14:2945–2952. doi:10.1021/bm400898t
Sponner A et al (2005) Characterization of the protein components of Nephila clavipes dragline silk. Biochemistry 44:4727–4736. doi:10.1021/bi047671k
Jin H-J, Kaplan D (2003) Mechanism of silk processing in insects and spiders. Nature 424:1057–1061. doi:10.1038/nature01809
Hayashi C, Shipley N, Lewis R (1999) Hypotheses that correlate the sequence, structure, and mechanical properties of spider silk proteins. Int J Biol Macromol 24:271–275. doi:10.1016/S0141-8130(98)00089-0
Tokareva O, Jacobsen M, Buehler M, Wong J, Kaplan D (2014) Structure-function-property-design interplay in biopolymers: spider silk. Acta Biomater 10:1612–1626. doi:10.1016/j.actbio.2013.08.020
Ayoub N, Garb J, Tinghitella R, Collin M, Hayashi C (2007) Blueprint for a high-performance biomaterial: full-length spider dragline silk genes. PLoS One 2:e514. doi:10.1371/journal.pone.0000514
Tokareva O et al (2014) Effect of sequence features on assembly of spider silk block copolymers. J Struct Biol 186:412. doi:10.1016/j.jsb.2014.03.004
Askarieh G et al (2010) Self-assembly of spider silk proteins is controlled by a pH-sensitive relay. Nature 465:236–238. doi:10.1038/nature08962
Gaines W, Sehorn M, Marcotte W (2010) Spidroin N-terminal domain promotes a pH-dependent association of silk proteins during self-assembly. J Biol Chem 285:40745–40753. doi:10.1074/jbc.M110.163121
Kronqvist N et al (2014) Sequential pH-driven dimerization and stabilization of the N-terminal domain enables rapid spider silk formation. Nat Commun 5:3254. doi:10.1038/ncomms4254
Schwarze S, Zwettler F, Johnson C, Neuweiler H (2013) The N-terminal domains of spider silk proteins assemble ultrafast and protected from charge screening. Nat Commun 4:2815. doi:10.1038/ncomms3815
Rising A, Widhe M, Johansson J, Hedhammar M (2011) Spider silk proteins: recent advances in recombinant production, structure-function relationships and biomedical applications. Cell Mol Life Sci 68:169–184. doi:10.1007/s00018-010-0462-z
Lefèvre T, Boudreault S, Cloutier C, Pézolet M (2008) Conformational and orientational transformation of silk proteins in the major ampullate gland of Nephila clavipes spiders. Biomacromolecules 9:2399–2407. doi:10.1021/bm800390j
Hronska M, van Beek J, Williamson P, Vollrath F, Meier B (2004) NMR characterization of native liquid spider dragline silk from Nephila edulis. Biomacromolecules 5:834–839. doi:10.1021/bm0343904
Knight D, Vollrath F (2001) Changes in element composition along the spinning duct in a Nephila spider. Naturwissenschaften 88:179–182. doi:10.1007/s001140100220
Vollrath F, Knight DP, Hu XW (1998) Silk production in a spider involves acid bath treatment. Proc R Soc B Biol Sci 265:817. doi:10.1098/rspb.1998.0365
Rousseau M-E, Lefèvre T, Pézolet M (2009) Conformation and orientation of proteins in various types of silk fibers produced by Nephila clavipes spiders. Biomacromolecules 10:2945–2953. doi:10.1021/bm9007919
Lefèvre T, Boudreault S, Cloutier C, Pézolet M (2011) Diversity of molecular transformations involved in the formation of spider silks. J Mol Biol 405:238–253. doi:10.1016/j.jmb.2010.10.052
Hu X et al (2006) Molecular mechanisms of spider silk. Cell Mol Life Sci 63:1986–1999. doi:10.1007/s00018-006-6090-y
Zhou C et al (2000) Fine organization of Bombyx mori fibroin heavy chain gene. Nucleic Acids Res 28:2413–2419. doi:10.1093/nar/28.12.2413
Zhou CZ et al (2001) Silk fibroin: structural implications of a remarkable amino acid sequence. Proteins 44:119–122
Wenk E, Merkle H, Meinel L (2011) Silk fibroin as a vehicle for drug delivery applications. J Control Release 150:128–141. doi:10.1016/j.jconrel.2010.11.007
Asakura T et al (2003) Synthesis and characterization of chimeric silkworm silk. Biomacromolecules 4:815–820. doi:10.1021/bm034020f
Bini E, Knight D, Kaplan D (2004) Mapping domain structures in silks from insects and spiders related to protein assembly. J Mol Biol 335:27–40. doi:10.1016/j.jmb.2003.10.043
Inoue S et al (2000) Silk fibroin of Bombyx mori is secreted, assembling a high molecular mass elementary unit consisting of H-chain, L-chain, and P25, with a 6:6:1 molar ratio. J Biol Chem 275:40517–40528. doi:10.1074/jbc.M006897200
Takasu Y et al (2007) Identification and characterization of a novel sericin gene expressed in the anterior middle silk gland of the silkworm Bombyx mori. Insect Biochem Mol Biol 37:1234–1240. doi:10.1016/j.ibmb.2007.07.009
Lammel A, Hu X, Park S-H, Kaplan D, Scheibel T (2010) Controlling silk fibroin particle features for drug delivery. Biomaterials 31:4583–4591. doi:10.1016/j.biomaterials.2010.02.024
Jin Y et al (2013) In vitro studies on the structure and properties of silk fibroin aqueous solutions in silkworm. Int J Biol Macromol 62:162–166. doi:10.1016/j.ijbiomac.2013.08.027
Chen X, Shao Z, Knight D, Vollrath F (2007) Conformation transition kinetics of Bombyx mori silk protein. Proteins 68:223–231. doi:10.1002/prot.21414
Foo CWP et al (2005) Role of pH and charge on silk protein assembly in insects and spiders. Appl Phys A 82:223. doi:10.1007/s00339-005-3426-7
Rockwood D et al (2011) Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 6:1612–1631. doi:10.1038/nprot.2011.379
Banani K et al (2014) Silk proteins for biomedical applications: bioengineering perspectives. Prog Polym Sci 39:251. doi:10.1016/j.progpolymsci.2013.09.002
Subia B, Kundu S (2013) Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers. Nanotechnology 24:35103. doi:10.1088/0957-4484/24/3/035103
Wadbua P, Promdonkoy B, Maensiri S, Siri S (2010) Different properties of electrospun fibrous scaffolds of separated heavy-chain and light-chain fibroins of Bombyx mori. Int J Biol Macromol 46:493–501. doi:10.1016/j.ijbiomac.2010.03.007
Subia B, Chandra S, Talukdar S, Kundu S (2014) Folate conjugated silk fibroin nanocarriers for targeted drug delivery. Integr Biol 6:203–214. doi:10.1039/c3ib40184g
Fei X et al (2013) Green synthesis of silk fibroin-silver nanoparticle composites with effective antibacterial and biofilm-disrupting properties. Biomacromolecules 14:4483–4488. doi:10.1021/bm4014149
Hai-Bo Y, Yu-Qing Z, Yong-Lei M, Li-Xia Z (2008) Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system. J Nanopart Res 11:1937. doi:10.1007/s11051-008-9549-y
Wang X, Yucel T, Lu Q, Hu X, Kaplan D (2010) Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials 31:1025–1035. doi:10.1016/j.biomaterials.2009.11.002
Yu-Qing Z, Yuan-Jing W, Hai-Yan W, Lin Z, Zhen-Zhen Z (2011) Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system. Soft Matter 7:9728. doi:10.1039/c0sm01332c
Kundu J, Chung Y-I, Kim Y, Tae G, Kundu S (2010) Silk fibroin nanoparticles for cellular uptake and control release. Int J Pharm 388:242–250. doi:10.1016/j.ijpharm.2009.12.052
Chung H, Kim T, Lee S (2012) Recent advances in production of recombinant spider silk proteins. Curr Opin Biotechnol 23:957–964. doi:10.1016/j.copbio.2012.03.013
Lewis R, Hinman M, Kothakota S, Fournier M (1996) Expression and purification of a spider silk protein: a new strategy for producing repetitive proteins. Protein Expr Purif 7:400–406. doi:10.1006/prep.1996.0060
Teulé F et al (2009) A protocol for the production of recombinant spider silk-like proteins for artificial fiber spinning. Nat Protoc 4:341–355. doi:10.1038/nprot.2008.250
Hauptmann V et al (2013) Native-sized spider silk proteins synthesized in planta via intein-based multimerization. Transgenic Res 22:369–377. doi:10.1007/s11248-012-9655-6
Teulé F et al (2012) Silkworms transformed with chimeric silkworm/spider silk genes spin composite silk fibers with improved mechanical properties. Proc Natl Acad Sci U S A 109:923–928. doi:10.1073/pnas.1109420109
Wen H et al (2010) Transgenic silkworms (Bombyx mori) produce recombinant spider dragline silk in cocoons. Mol Biol Rep 37:1815–1821. doi:10.1007/s11033-009-9615-2
Yu-Qing Z et al (2006) Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization. J Nanopart Res 9:885. doi:10.1007/s11051-006-9162-x
Wang X, Kaplan D (2011) Functionalization of silk fibroin with NeutrAvidin and biotin. Macromol Biosci 11:100–110. doi:10.1002/mabi.201000173
Liu J et al (2013) Preparation of ZnFe2O4 nanoparticles in the template of silk-fibroin peptide and their neuro-cytocompatibility in PC12 cells. Colloids Surf B Biointerfaces 107:19–26. doi:10.1016/j.colsurfb.2013.01.072
Mandal B, Kundu S (2009) Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery. Nanotechnology 20:355101. doi:10.1088/0957-4484/20/35/355101
Hofer M, Winter G, Myschik J (2012) Recombinant spider silk particles for controlled delivery of protein drugs. Biomaterials 33:1554–1562. doi:10.1016/j.biomaterials.2011.10.053
Cao T-T, Zhou Z-Z, Zhang Y-Q (2014) Processing of β-glucosidase-silk fibroin nanoparticle bioconjugates and their characteristics. Appl Biochem Biotechnol 173:544. doi:10.1007/s12010-014-0861-y
Wu P et al (2013) Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. ACS Appl Mater Interfaces 5:12638–12645. doi:10.1021/am403992b
Lammel A, Schwab M, Hofer M, Winter G, Scheibel T (2011) Recombinant spider silk particles as drug delivery vehicles. Biomaterials 32:2233–2240. doi:10.1016/j.biomaterials.2010.11.060
Zheng Z et al (2013) Generation of silk fibroin nanoparticles via solution-enhanced dispersion by supercritical CO2. Ind Eng Chem Res 52:3752. doi:10.1021/ie301907f
Zheng Z et al (2012) Fabrication of silk fibroin nanoparticles for controlled drug delivery. J Nanopart Res 14:736. doi:10.1007/s11051-012-0736-5
Björnmalm M, Yan Y, Caruso F (2014) Engineering and evaluating drug delivery particles in microfluidic devices. J Control Release 190:139–149. doi:10.1016/j.jconrel.2014.04.030
Karnik R et al (2008) Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett 8:2906–2912. doi:10.1021/nl801736q
Mitropoulos A et al (2014) Synthesis of silk fibroin micro- and submicron spheres using a co-flow capillary device. Adv Mater 26:1105–1110. doi:10.1002/adma.201304244
Chen M, Shao Z, Chen X (2012) Paclitaxel-loaded silk fibroin nanospheres. J Biomed Mater Res A 100:203–210. doi:10.1002/jbm.a.33265
Gupta V, Aseh A, Ríos C, Aggarwal B, Mathur A (2009) Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int J Nanomedicine 4:115–122
Hanjin O, Moo Kon K, Ki Hoon L (2011) Preparation of sericin microparticles by electrohydrodynamic spraying and their application in drug delivery. Macromol Res 19:266. doi:10.1007/s13233-011-0301-6
Numata K, Yamazaki S, Naga N (2012) Biocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticles. Biomacromolecules 13:1383–1389. doi:10.1021/bm300089a
Aramwit P, Kanokpanont S, Nakpheng T, Srichana T (2010) The effect of sericin from various extraction methods on cell viability and collagen production. Int J Mol Sci 11:2200–2211. doi:10.3390/ijms11052200
Lu Y, Yang J, Sega E (2005) Issues related to targeted delivery of proteins and peptides. AAPS J 8:78. doi:10.1208/aapsj080355
McGregor DP (2008) Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 8:616–619. doi:10.1016/j.coph.2008.06.002
Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41:2971–3010. doi:10.1039/c2cs15344k
Wang S, Low P (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 53:39–48. doi:10.1016/S0168-3659(97)00236-8
Gruner B, Weitman S (1998) The folate receptor as a potential therapeutic anticancer target. Invest New Drugs 16:205–219. doi:10.1023/A:1006147932159
Xia X-X, Xu Q, Hu X, Qin G, Kaplan D (2011) Tunable self-assembly of genetically engineered silk—elastin-like protein polymers. Biomacromolecules 12:3844–3850. doi:10.1021/bm201165h
Anderson J, Cappello J, Martin D (1994) Morphology and primary crystal structure of a silk-like protein polymer synthesized by genetically engineered Escherichia coli bacteria. Biopolymers 34:1049–1058. doi:10.1002/bip.360340808
Anumolu R et al (2011) Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery. ACS Nano 5:5374–5382. doi:10.1021/nn103585f
Numata K, Reagan M, Goldstein R, Rosenblatt M, Kaplan D (2011) Spider silk-based gene carriers for tumor cell-specific delivery. Bioconjug Chem 22:1605–1610. doi:10.1021/bc200170u
Nathwani B, Jaffari M, Juriani A, Mathur A, Meissner K (2009) Fabrication and characterization of silk-fibroin-coated quantum dots. IEEE Trans Nanobiosci 8:72–77. doi:10.1109/TNB.2009.2017295
Martínez-Gutierrez F et al (2012) Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomedicine 8:328–336. doi:10.1016/j.nano.2011.06.014
Ratan D (2011) Preparation and antibacterial activity of silver nanoparticles. J Biomater Nanobiotechnol 2:472. doi:10.4236/jbnb.2011.24057
Suliman YA et al (2015) Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells. Environ Toxicol 30(2):149–160. doi:10.1002/tox.21880
Prasad R et al (2013) Investigating oxidative stress and inflammatory responses elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: effect of size, surface coating, and intracellular uptake. Toxicol In Vitro 27:2013–2021. doi:10.1016/j.tiv.2013.07.005
Avalos A, Haza A, Mateo D, Morales P (2014) Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells. J Appl Toxicol 34:413–423. doi:10.1002/jat.2957
Ramírez-Lee M et al (2014) Silver nanoparticles induce anti-proliferative effects on airway smooth muscle cells. Role of nitric oxide and muscarinic receptor signaling pathway. Toxicol Lett 224:246–256. doi:10.1016/j.toxlet.2013.10.027
Aramwit P, Bang N, Ratanavaraporn J, Ekgasit S (2014) Green synthesis of silk sericin-capped silver nanoparticles and their potent anti-bacterial activity. Nanoscale Res Lett 9:79. doi:10.1186/1556-276X-9-79
Bruchez M Jr (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013. doi:10.1126/science.281.5385.2013
Jamieson T et al (2007) Biological applications of quantum dots. Biomaterials 28:4717–4732. doi:10.1016/j.biomaterials.2007.07.014
Teak Kwan K, Kun Bin L, Jin-Chul K (2011) Solid lipid nanoparticles coated with silk fibroin. J Ind Eng Chem 17:10. doi:10.1016/j.jiec.2010.10.001
Barichello J et al (2006) Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state. J Control Release 115:94–102. doi:10.1016/j.jconrel.2006.07.008
Acharya A (2013) Luminescent magnetic quantum dots for in vitro/in vivo imaging and applications in therapeutics. J Nanosci Nanotechnol 13:3753–3768. doi:10.1166/jnn.2013.7460
Larrondo L, Manley RSJ (1981) Electrostatic fiber spinning from polymer melts: I. Experimental observations on fiber formation and properties. J Polym Sci Polym Phys Ed 19:909. doi:10.1002/pol.1981.180190601
Shin YM, Hohman MM, Brenner MP, Rutledge GC (2001) Experimental characterization of electrospinning: the electrically forced jet and instabilities. Polymer 42:9955. doi:10.1016/S0032-3861(01)00540-7
Sill T, von Recum H (2008) Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 29:1989–2006. doi:10.1016/j.biomaterials.2008.01.011
Thangaraju E, Govindaswamy M, Sheeja R, Thirupathur Srinivasan N (2014) Curcumin loaded electrospun Bombyx mori silk nanofibers for drug delivery. Polym Int 63:100. doi:10.1002/pi.4499
Jingwen Q et al (2013) Evaluation of drug release property and blood compatibility of aspirin-loaded electrospun PLA/RSF composite nanofibers. Iran Polym J 22:729. doi:10.1007/s13726-013-0171-1
Sheikh F et al (2013) Facile and highly efficient approach for the fabrication of multifunctional silk nanofibers containing hydroxyapatite and silver nanoparticles. J Biomed Mater Res A 102:3459. doi:10.1002/jbm.a.35024
David MW, Padma S, Mark EB (2013) Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics. Eur J Pharm Biopharm 84:1. doi:10.1016/j.ejpb.2012.12.009
Couvreur P (2013) Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev 65:21–23. doi:10.1016/j.addr.2012.04.010
Sheikh F et al (2013) A novel approach to fabricate silk nanofibers containing hydroxyapatite nanoparticles using a three-way stopcock connector. Nanoscale Res Lett 8:303. doi:10.1186/1556-276X-8-303
Gregory HA et al (2003) Silk-based biomaterials. Biomaterials 24:401
Yongzhong W et al (2008) In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 29:3415. doi:10.1016/j.biomaterials.2008.05.002
Keiji N, Peggy C, David LK (2010) Mechanism of enzymatic degradation of beta-sheet crystals. Biomaterials 31:2926. doi:10.1016/j.biomaterials.2009.12.026
Zhang J et al (2012) Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A 109:11981–11986. doi:10.1073/pnas.1206210109
Nicholas AG, Andrew JM, Bernardo JP-R, David LK (2013) Mechanisms of monoclonal antibody stabilization and release from silk biomaterials. Biomaterials 34(31):7766–7775
Shenzhou L et al (2009) Stabilization of enzymes in silk films. Biomacromolecules 10:1032. doi:10.1021/bm800956n
Claudia B, Alfons N, Thomas S (2014) Spider silk capsules as protective reaction containers for enzymes. Adv Funct Mater 24:763. doi:10.1002/adfm.201302100
Pritchard EM, Szybala C, Boison D, Kaplan DL (2010) Silk fibroin encapsulated powder reservoirs for sustained release of adenosine. J Control Release 144:159–167. doi:10.1016/j.jconrel.2010.01.035
Bayraktar O, Malay O, Ozgarip Y, Batigün A (2005) Silk fibroin as a novel coating material for controlled release of theophylline. Eur J Pharm Biopharm 60(3):373–381. doi:10.1016/j.ejpb.2005.02.002
Hofmann S et al (2006) Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 111:219. doi:10.1016/j.jconrel.2005.12.009
Olga S, Irina D, Maneesh KG, Jeffrey L, Vladimir VT (2011) Silk-on-silk layer-by-layer microcapsules. Adv Mater 23(40):4655–4660. doi:10.1002/adma.201102234
Hermanson KD, Harasim MB, Scheibel T, Bausch AR (2007) Permeability of silk microcapsules made by the interfacial adsorption of protein. Phys Chem Chem Phys 9:6442–6446. doi:10.1039/b709808a
Langer R (1980) Invited review polymeric delivery systems for controlled drug release. Chem Eng Commun 6:148. doi:10.1080/00986448008912519
Pritchard EM, Hu X, Finley V, Kuo CK, Kaplan DL (2013) Effect of silk protein processing on drug delivery from silk films. Macromol Biosci 13:311–320. doi:10.1002/mabi.201200323
Oroudjev E et al (2002) Segmented nanofibers of spider dragline silk: atomic force microscopy and single-molecule force spectroscopy. Proc Natl Acad Sci U S A 99:6460–6465. doi:10.1073/pnas.082526499
Jia-You F, Jyh-Ping C, Yann-Lii L, Hsin-Yuan W (2006) Characterization and evaluation of silk protein hydrogels for drug delivery. Chem Pharm Bull 54:156
Uebersax L, Merkle HP, Meinel L (2008) Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 127:12–21. doi:10.1016/j.jconrel.2007.11.006
Wei K, Kim I-S (2013) Fabrication of nanofibrous scaffolds by electrospinning. In: Russell M (ed) Nanotechnology and nanomaterials, Advances in nanofibers, book edited by Russell Maguire. InTech, Rijeka, Croatia. doi:10.5772/57093. ISBN 978-953-51-1209-9
Hongbin F, Haifeng L, Siew LT, James CHG (2009) Anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold in large animal model. Biomaterials 30:4967
CeledÓN JC et al (2001) Asthma, rhinitis, and skin test reactivity to aeroallergens in families of asthmatic subjects in Anqing. China Am J Respir Crit Care Med 163:1108–1112. doi:10.1164/ajrccm.163.5.2005086
Wray LS et al (2011) Effect of processing on silk-based biomaterials: reproducibility and biocompatibility. J Biomed Mater Res B Appl Biomater 99:89–101. doi:10.1002/jbm.b.31875
Banani K, Rangam R, Subhas CK, Xungai W (2013) Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev 65:457
Yongzhong W, Hyeon-Joo K, Gordana V-N, David LK (2006) Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27:6064. doi:10.1016/j.biomaterials.2006.07.008
Pritchard EM, Kaplan DL (2011) Silk fibroin biomaterials for controlled release drug delivery. Expert Opin Drug Deliv 8:797–811. doi:10.1517/17425247.2011.568936
Ute KS, Sebastian R, Stanislav G, Thomas S (2008) An engineered spider silk protein forms microspheres. Angew Chem Int Ed Engl 47(24):4592–4594. doi:10.1002/anie.200800683
Yucel T, Kojic N, Leisk GG, Lo TJ, Kaplan DL (2010) Non-equilibrium silk fibroin adhesives. J Struct Biol 170:406–412. doi:10.1016/j.jsb.2009.12.012
Ribeiro M, de Moraes MA, Beppu MM, Monteiro FJ, Ferraz MP (2014) The role of dialysis and freezing on structural conformation, thermal properties and morphology of silk fibroin hydrogels. Biomatter 4:e28536
Kim UJ et al (2004) Structure and properties of silk hydrogels. Biomacromolecules 5:786–792. doi:10.1021/bm0345460
Minoura N, Tsukada M, Nagura M (1990) Physico-chemical properties of silk fibroin membrane as a biomaterial. Biomaterials 11:430–434
Jin HJ et al (2005) Water-stable silk films with reduced β-sheet content. Adv Funct Mater 15:1241. doi:10.1002/adfm.200400405
Hu X et al (2011) Regulation of silk material structure by temperature-controlled water vapor annealing. Biomacromolecules 12:1686–1696. doi:10.1021/bm200062a
Wang X et al (2007) Silk microspheres for encapsulation and controlled release. J Control Release 117:360–370. doi:10.1016/j.jconrel.2006.11.021
Kojthung A et al (2008) Effects of gamma radiation on biodegradation of Bombyx mori silk fibroin. Int Biodeterior Biodegradation 62:487–490. doi:10.1016/j.ibiod.2007.12.012
Li C, Vepari C, Jin H-JJ, Kim HJ, Kaplan DL (2006) Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27:3115–3124. doi:10.1016/j.biomaterials.2006.01.022
Kim UJ, Park J, Kim HJ, Wada M, Kaplan DL (2005) Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26:2775–2785. doi:10.1016/j.biomaterials.2004.07.044
Xianyan W et al (2007) Nanolayer biomaterial coatings of silk fibroin for controlled release. J Control Release 121:190. doi:10.1016/j.jconrel.2007.06.006
Wang X et al (2008) Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 29:894–903. doi:10.1016/j.biomaterials.2007.10.055
Xiaoqin W et al (2007) Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28:4161. doi:10.1016/j.biomaterials.2007.05.036
Wang X, Kluge JA, Leisk GG, Kaplan DL (2008) Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials 29:1054–1064. doi:10.1016/j.biomaterials.2007.11.003
Tuna Y, Peggy C, David LK (2009) Vortex-induced injectable silk fibroin hydrogels. Biophys J 97:2044. doi:10.1016/j.bpj.2009.07.028
Benjamin PP et al (2014) Highly tunable elastomeric silk biomaterials. Adv Funct Mater 24:4615. doi:10.1002/adfm.201400526
Charu PV, David LK (2006) Covalently immobilized enzyme gradients within three‐dimensional porous scaffolds. Biotechnol Bioeng 93(6):1130–1137. doi:10.1002/bit.20833
Susan S, Mary Beth M, Gloria G, David LK (2001) Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54:139. doi:10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
Meinel L et al (2006) Silk based biomaterials to heal critical sized femur defects. Bone 39:922. doi:10.1016/j.bone.2006.04.019
Esther W et al (2010 Feb) The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials 31(6):1403–1413. doi:10.1016/j.biomaterials.2009.11.006
Amanda RM, Peter St J, David LK (2008 Jul) Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation. Biomaterials 29(19):2829–2838. doi:10.1016/j.biomaterials.2008.03.039
Yasushi T (2004) Sulfation of silk fibroin by chlorosulfonic acid and the anticoagulant activity. Biomaterials 25:377. doi:10.1016/S0142-9612(03)00533-7
Mona W et al (2010) Recombinant spider silk as matrices for cell culture. Biomaterials 31:9575. doi:10.1016/j.biomaterials.2010.08.061
Keiji N, Juliana H, Balajikarthick S, David LK (2010) Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs. J Control Release 146:136. doi:10.1016/j.jconrel.2010.05.006
Keiji N, Balajikarthick S, Heather AC, David LK (2009) Bioengineered silk protein-based gene delivery systems. Biomaterials 30:5775. doi:10.1016/j.biomaterials.2009.06.028
Germershaus O, Werner V, Kutscher M, Meinel L (2014) Deciphering the mechanism of protein interaction with silk fibroin for drug delivery systems. Biomaterials 35:3427–3434. doi:10.1016/j.biomaterials.2013.12.083
Manunya O, Ratthapol R, Sorada K, Siriporn D (2010) Preparation of Thai silk fibroin/gelatin electrospun fiber mats for controlled release applications. Int J Biol Macromol 46:544. doi:10.1016/j.ijbiomac.2010.02.008
Wenk E, Wandrey AJ, Merkle HP, Meinel L (2008) Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 132:26–34. doi:10.1016/j.jconrel.2008.08.005
Guziewicz N, Best A, Perez-Ramirez B, Kaplan DL (2011) Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies. Biomaterials 32:2642–2650. doi:10.1016/j.biomaterials.2010.12.023
Lauzon MA, Bergeron E, Marcos B, Faucheux N (2012) Bone repair: new developments in growth factor delivery systems and their mathematical modeling. J Control Release 162:502–520. doi:10.1016/j.jconrel.2012.07.041
Naresh K, Utpal B (2012) Silk fibroin in tissue engineering advanced healthcare. Materials 1:393. doi:10.1002/adhm.201200097
Hardy JG, Scheibel TR (2010) Composite materials based on silk proteins. Prog Polym Sci 35:1093–1115. doi:10.1016/j.progpolymsci.2010.04.005
Tomoaki H, Masao T, Saburo S (2003) Change in secondary structure of silk fibroin during preparation of its microspheres by spray-drying and exposure to humid atmosphere. J Colloid Interface Sci 266:68. doi:10.1016/S0021-9797(03)00584-8
Lammel A, Schwab M, Slotta U, Winter G, Scheibel T (2007) Processing conditions for the formation of spider silk microspheres. ChemSusChem 1:413–416. doi:10.1002/cssc.200800030
Rammensee S, Slotta U, Scheibel T, Bausch AR (2008) Assembly mechanism of recombinant spider silk proteins. Proc Natl Acad Sci U S A 105:6590–6595. doi:10.1073/pnas.0709246105
Cheng C, Teasdale I, Brüggemann O (2014) Stimuli-responsive capsules prepared from regenerated silk fibroin microspheres. Macromol Biosci 14:807. doi:10.1002/mabi.201300497
Donath E, Sukhorukov G, Caruso F, Davis S, Möhwald H (1998) Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes. Angew Chem Int Ed 37:2201. doi:10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E
Yi-You H, Ching-Hua W (2006) Pulmonary delivery of insulin by liposomal carriers. J Control Release 113:9. doi:10.1016/j.jconrel.2006.03.014
Huang X, Brazel CS (2001) On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 73:121
Xiao H et al (2010) Biomaterials from ultrasonication-induced silk fibroin-hyaluronic acid hydrogels. Biomacromolecules 11:3178. doi:10.1021/bm1010504
Kristin S, Thomas S (2011) Controlled hydrogel formation of a recombinant spider silk protein. Biomacromolecules 12:2488. doi:10.1021/bm200154k
Gyung-Don K et al (2000) Effects of poloxamer on the gelation of silk fibroin. Macromol Rapid Commun 21:788. doi:10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
Emmett PB et al (2005) Enzymatic stabilization of gelatin-based scaffolds. J Biomed Mater Res 72:37. doi:10.1002/jbm.b.30119
Liora A, Dror S (2005) Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26:2467
Rowley JA, Madlambayan G, Mooney DJ (1999) Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45
Pritchard EM, Valentin T, Panilaitis B, Omenetto F, Kaplan DL (2013) Antibiotic-releasing silk biomaterials for infection prevention and treatment. Adv Funct Mater 23:854–861. doi:10.1002/adfm.201201636
Nogueira GM, de Moraes MA, Rodas ACD, Higa OZ, Beppu MM (2011) Hydrogels from silk fibroin metastable solution: formation and characterization from a biomaterial perspective. Mater Sci Eng C 31:997–1001. doi:10.1016/j.msec.2011.02.019
Matsumoto A et al (2006) Mechanisms of silk fibroin sol-gel transitions. J Phys Chem B 110:21630–21638. doi:10.1021/jp056350v
Gary GL, Tim JL, Tuna Y, Qiang L, David LK (2010) Electrogelation for protein adhesives. Adv Mater 22:711. doi:10.1002/adma.200902643
Wang X et al (2009) Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134:81–90. doi:10.1016/j.jconrel.2008.10.021
Uebersax L et al (2007) Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials 28:4449–4460. doi:10.1016/j.biomaterials.2007.06.034
Greish K et al (2009) Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. Biomacromolecules 10:2183–2188. doi:10.1021/bm900356j
Megeed Z et al (2004) In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Control Release 94:433–445. doi:10.1016/j.jconrel.2003.10.027
Fischell TA (1996) Polymer coatings for stents. Can we judge a stent by its cover? Circulation 94:1494–1495
Kang Y et al (2008) Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J Colloid Interface Sci 322:87–94. doi:10.1016/j.jcis.2008.02.031
Peter GC (2008) Breast reconstruction after surgery for breast cancer. N Engl J Med 359:1590. doi:10.1056/NEJMct0802899
Zeplin PH et al (2014) Spider silk coatings as a bioshield to reduce periprosthetic fibrous capsule formation. Adv Funct Mater 24:2658. doi:10.1002/adfm.201302813
Jeffrey JR et al (2013) Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater 2:57. doi:10.1002/adhm.201200197
Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428:487–492. doi:10.1038/nature02388
Eun Seok G, Bruce P, Evangelia B, David LK (2013) Functionalized silk biomaterials for wound healing. Adv Healthc Mater 2:206. doi:10.1002/adhm.201200192
Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C (2009) Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater 5(7):2570–2578. doi:10.1016/j.actbio.2008.12.013
Wenk E, Meinel AJ, Wildy S, Merkle HP, Meinel L (2009) Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials 30:2571–2581. doi:10.1016/j.biomaterials.2008.12.073
Acknowledgements
This work was supported by a Program of Excellence in Nanotechnology (PEN) Award, Contract #HHSN268201000045C, from the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH). This work was also supported by NIH grants CA151884 and the David Koch-Prostate Cancer Foundation Award in Nanotherapeutics.
Conflict of interest statement Dr. Farokhzad declares financial interests in BIND Therapeutics, Selecta Biosciences, Tarveda Therapeutics and Playcon Therapeutics, four biotechnology companies developing nanoparticle technologies for medical applications. All other authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Controlled Release Society
About this chapter
Cite this chapter
Chiasson, R., Hasan, M., Al Nazer, Q., Farokhzad, O.C., Kamaly, N. (2016). The Use of Silk in Nanomedicine Applications. In: Howard, K., Vorup-Jensen, T., Peer, D. (eds) Nanomedicine. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3634-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3634-2_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3632-8
Online ISBN: 978-1-4939-3634-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)